-
Product Insights
NewQuarterly Herbs, Spices & Seasonings pricing trends in the United Kingdom
Empower your strategies with our Quarterly Herbs, Spices & Seasonings pricing trends in the United Kingdom report and make more profitable business decisions. Consumers’ preferences for stores are most heavily influenced by pricing and promotions, but brands and retailers continue to adjust prices and promotions based on insufficient information from expensive, drawn-out, and incomplete audits of rival techniques. Brands and retailers can benefit from the unique intelligence provided by GlobalData Ecommerce Price Tracker, covering millions of SKUs, to identify, anticipate,...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – INA-03 in Relapsed Acute Myeloid Leukemia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - INA-03 in Relapsed Acute Myeloid Leukemia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.INA-03 in Relapsed Acute Myeloid Leukemia Drug Details:INA-03 is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – INA-03 in Refractory Acute Myeloid Leukemia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - INA-03 in Refractory Acute Myeloid Leukemia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.INA-03 in Refractory Acute Myeloid Leukemia Drug Details:INA-03 is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – INA-03 in Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - INA-03 in Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. INA-03 in Acute Lymphocytic Leukemia (ALL, Acute...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – TACH-101 in Breast Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. TACH-101 in Breast Cancer Drug Details: TACH-101Â (formerly QC8222) is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Vixarelimab in Erosive Oral Lichen Planus
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Vixarelimab in Erosive Oral Lichen Planus report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Vixarelimab in Erosive Oral Lichen PlanusDrug Details:Vixarelimab (KPL-716) is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – F-598 in Hospital-Acquired Infections
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - F-598 in Hospital-Acquired Infections report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.F-598 in Hospital-Acquired Infections Drug Details:F598 (SAR-279356) is under development for the treatment...
-
Sector Analysis
Bermuda Insurance Industry – Key Trends and Opportunities to 2027
Bermuda Insurance Industry Report Overview The total gross written premium (GWP) in the Bermuda insurance industry was BMD286.6 billion in 2022 and is expected to record a CAGR of more than 6% during 2023-2027. The following are some of the key highlights of the Bermuda insurance market: Bermuda’s economy is mainly driven by international business and tourism, which contributed to real GDP growth in 2022. With tighter monetary conditions and lower growth potentially affecting financial and debt stability, it is...
-
Product Insights
INA DD/ INA-R-A – Rijeka Refinery Upgrade – Primorsko-Goranska
Equip yourself with the essential tools needed to make informed and profitable decisions with our INA DD/ INA-R-A - Rijeka Refinery Upgrade - Primorsko-Goranska report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep into...
-
Product Insights
Croatia Gov/ INA DD – Sisak BioRefinery Plant – Sisacko-Moslavacka
Equip yourself with the essential tools needed to make informed and profitable decisions with our Croatia Gov/ INA DD - Sisak BioRefinery Plant - Sisacko-Moslavacka report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep...